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The carbon catabolite repression 4 (CCR4)–negative on TATA-less (NOT) complex serves
as one of the major deadenylases of eukaryotes. Although it was originally identiﬁed
and characterized in yeast, recent studies have revealed that the CCR4–NOT complex
also exerts important functions in mammals, -including humans. However, there are
some differences in the composition and functions of the CCR4–NOT complex between
mammals and yeast. It is noteworthy that each subunit of the CCR4–NOT complex has
unique, multifunctional roles and is responsible for various physiological phenomena. This
heterogeneity and versatility of the CCR4–NOT complex makes an overall understanding
of this complex difﬁcult. Here, we describe the functions of each subunit of the
mammalian CCR4–NOT complex and discuss the molecular mechanisms by which it
regulates homeostasis in mammals. Furthermore, a possible link between the disruption
of the CCR4–NOT complex and various diseases will be discussed. Finally, we propose
that the analysis of mice with each CCR4–NOT subunit knocked out is an effective strategy
for clarifying its complicated functions and networks in mammals.
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INTRODUCTION
Carbon catabolite repression 4 (CCR4)–negative on TATA-less
(NOT) is a versatile complex that regulates various physiological
processes in eukaryotes (Collart, 2003). Of its diverse functions,
including transcriptional regulation and protein modiﬁcation,
deadenylation of mRNA has been particularly highlighted. Short-
ening of poly(A) tails leads to the degradation of mRNA via one
of two ways, i.e., 5′–3′ digestion by XRN1 after decapping by
DCP1–DCP2 or 3′–5′ digestion by the exosome, consequently
suppressing gene expression (see Bartlam and Yamamoto, 2010;
Doidge et al., 2012a for more details). In mammals, deadenylation
is tightly regulated by various enzymes, such as poly(A)-speciﬁc
ribonuclease (PARN), PAN2–PAN3, Nocturnin, and Angel1/2, as
well as CCR4–NOT (Wiederhold and Passmore, 2010; Doidge
et al., 2012a). Among these enzymes, PAN2–PAN3 and CCR4–
NOT are considered to be dominant in mammalian cells because
cytoplasmic mRNA decay is reported to be conducted in two
phases: an initial step by PAN2–PAN3 and a subsequent step
by CCR4–NOT (Yamashita et al., 2005; Bartlam and Yamamoto,
2010).
CCR4 was originally identiﬁed as a gene required for the reg-
ulation of glucose-repressible alcohol dehydrogenase 2 (ADH2)
in the yeast Saccharomyces cerevisiae (Denis, 1984). The Ccr4p-
associated factor (CAF1, also known as POP2) gene was found
to be required for glucose derepression (Sakai et al., 1992). These
two gene products were shown to form a large complex with Not
proteins, which are related to the regulation of HIS3 transcription
mainly through its TATA-less core promoter (Collart and Struhl,
1993, 1994). The core CCR4–NOT complex consists of Ccr4p,
Caf1p, ﬁve Not proteins (Not1p–Not5p), Caf40p, and Caf130p
in yeast (Chen et al., 2001). Further study revealed that Ccr4p
and Caf1p are the major cytoplasmic mRNA deadenylases in yeast
(Tucker et al., 2001; see below).
Initially, only the function of the CCR4–NOT complex in
transcription was investigated because the core components of
the complex were identiﬁed as possible transcriptional regulators
(Collart, 2003). However, as mentioned above, mRNA silencing
by the CCR4–NOT complex was then discovered. Thus, how the
CCR4–NOT complex determines targetmRNAs for degradation is
nowone of themore compelling questions. TheCCR4–NOTcom-
plex interacts with various proteins, including the BTG/Tob family,
RNA-binding proteins and miRNA-induced silencing complexes
(miRISCs), to specify target mRNAs (Doidge et al., 2012a). Cyto-
plasmic polyadenylation element-binding protein (CPEB) binds
speciﬁc mRNAs, to which Tob, as an adapter protein, mediates
the recruitment of the CCR4–NOT deadenylase (Hosoda et al.,
2011; Ogami et al., 2014). Other RNA-binding proteins, such as
Nanos, Pumilio and fem-3 binding factor (PUF) proteins, Smaug,
tristetrapolin (TTP), and Bicaudal-C (Bic-C), were reported to
interact with the components of CCR4–NOT and cause the sup-
pression of target mRNAs (Semotok et al., 2005; Goldstrohm et al.,
2006, 2007; Chicoine et al., 2007; Suzuki et al., 2010, 2012; Sandler
et al., 2011; Van Etten et al., 2012; Fabian et al., 2013; Joly et al.,
2013; Bhandari et al., 2014). In addition, CCR4–NOT is involved
in the microRNA (miRNA)-mediated deadenylation of mRNAs
through interaction with the GW182 proteins (Behm-Ansmant
et al., 2006; Braun et al., 2011; Chekulaeva et al., 2011; Fabian et al.,
2011).
The CCR4–NOT components in yeast, except for Caf130p, are
well conserved in mammals (Panepinto et al., 2013). CNOT1,
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CNOT2, CNOT4, and CNOT9 are mammalian orthologs of
Not1p, Not2p, Not4p, and Caf40p, respectively. However, there
are some compositional differences between the mammalian and
yeastCCR4–NOTcomplexes. First, the E3ubiquitin ligaseCNOT4
does not stably associate with the mammalian CCR4–NOT com-
plex (Lau et al., 2009). Second, there are four deadenylase subunits
in the mammalian CCR4–NOT complex; yeast Ccr4p, which
belongs to the exonuclease/endonuclease/phosphatase (EEP) fam-
ily, is diverged into CNOT6 and CNOT6L, and Caf1p, which
belongs to the DEDD (Asp-Glu-Asp-Asp) family, is into CNOT7
and CNOT8. The expression of these paralogs was reported to
be mutually exclusive in the human CCR4–NOT complex in
HeLa S3 cells (Lau et al., 2009). Third, CNOT3 is a mammalian
ortholog of two yeast Not proteins: Not3p and Not5p. Finally,
orthologs of mammalian CNOT10 and C2orf29 (CNOT11) are
missing in fungi (Mauxion et al., 2013; Panepinto et al., 2013).
As the function of some CCR4–NOT components is differ-
ent between yeast and mammals, it would be interesting to
compare their biological roles across species. The structural
organization and deadenylation machinery of the mammalian
CCR4–NOT complex can be proposed as shown in Figures 1A,B,
respectively.
FIGURE 1 |The mammalian carbon catabolite repression 4
(CCR4)–negative onTATA-less (NOT) complex exerts deadenylase
activities guided by RNA-binding proteins, miRISC andTob. (A)
Schematic structural organization of the mammalian CCR4–NOT complex.
It comprises either of CNOT6/6L and either of CNOT7/8 as deadenylase
subunits. (B) Schematic representation of deadenylation by the mammalian
CCR4–NOT complex. The CCR4–NOT complex is recruited to the 3′UTR of
speciﬁc mRNAs through an interaction with AU-rich RNA binding proteins
(AUBP) includingTTP. GW182 is a component of miRISC together with
miRNA and AGO.The CCR4–NOT complex is involved in the
miRNA-induced deadenylation through an association with GW182. Tob
also interacts with poly(A)-binding protein (PABP) and polyadenylation
element-binding protein (CPEB), and recruits the CCR4–NOT complex to
initiate deadenylation.
The CCR4–NOT complex is involved in various cellular mech-
anisms, including cell growth, DNA repair, mRNA export, histone
methylation, and protein quality control in yeast (Collart, 2003;
Mulder et al., 2005, 2007; Kerr et al., 2011; Halter et al., 2014).
The CCR4–NOT complex is also implicated in the regulation
of cell wall integrity, antifungal drug susceptibility, and devel-
opmental switches in pathogenic fungi (Panepinto et al., 2013).
As we describe here, recent studies using cultured mammalian
cells and genetically modiﬁed mice have revealed distinct roles of
each subunit in wide-ranging physiological phenomena. Further-
more, deviation in the expression of CCR4–NOT has been found
in various diseases based on analyses of human clinical specimens.
In this review, we focus on the physiology of the mammalian
CCR4–NOT complex and will occasionally refer to ﬁndings from
non-mammalian systems.
CNOT1
CNOT1 is the largest subunit of the CCR4–NOT complex in
molecular size and is a scaffold protein involved in the assem-
bly of CCR4–NOT components (Figure 1A). From a structural
point of view, CNOT1 can be divided into three main regions,
namely the N-terminal, the middle and the C-terminal, according
to structural predictions and information (Bawankar et al., 2013).
TheN-terminal region of CNOT1 associates withCNOT11,which
interactswithCNOT10 (Bawankar et al., 2013). Themiddle part of
CNOT1, named the MIF4G (middle domain of eukaryotic initia-
tion factor 4G) domain, directly interactswithCAF1a (CNOT7) or
CAF1b (CNOT8; Basquin et al., 2012; Petit et al., 2012; Bawankar
et al., 2013). In addition, CAF40 (CNOT9) interacts with the
remaining residues of the middle portion of CNOT1, which com-
prises aDUF3819 domain (Bawankar et al., 2013; Chen et al., 2014;
Mathys et al., 2014). Finally, theC-terminal regionof CNOT1asso-
ciates with the CNOT2/CNOT3 complex (Bawankar et al., 2013;
Boland et al., 2013). Through these interactions, CNOT1 provides
a scaffold function for complex formation. Accordingly, deple-
tion of CNOT1 destabilizes the complex, and each component
is degraded, resulting in decreased levels of CNOT2, CNOT6L,
CNOT7, and CNOT9, but not CNOT3, in HeLa cells (Ito et al.,
2011a).
CNOT1 is an indispensable component for the deadeny-
lase activities of the CCR4–NOT complex; however, CNOT1
does not possess any catalytic domains. Indeed, depletion of
CNOT1 in HeLa cells compromises the deadenylase activities and
decreases the number of P-bodies (Ito et al., 2011a), where mRNA
decay is thought to take place (see review by Parker and Sheth,
2007). CNOT1-depleted cells undergo caspase-dependent apopto-
sismost likely through endoplasmic reticulum(ER) stress resulting
from protein overproduction (Ito et al., 2011a).
CNOT1 also serves as a platform for the RNA-binding proteins
that determine the speciﬁcity of the CCR4–NOT deadenylase for
target mRNAs (Figure 1B). TTP, which is involved in AU-rich
element (ARE)-mediated mRNA decay, directly interacts with
CNOT1, and this interaction is required for the recruitment of
CNOT7 to targetmRNAs such as tumor necrosis factor-α (TNF-α)
to promote deadenylation (Sandler et al., 2011; Fabian et al., 2013).
In addition, mammalian Nanos paralogs (Nanos1, Nanos2, and
Nanos3) directly interact with the C-terminal domain of CNOT1
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(Suzuki et al., 2012; Bhandari et al., 2014). The interaction between
Nanos2 and CNOT1 plays an important role in murine male germ
cell development,most likely through regulation of the turnover of
speciﬁc mRNAs, such as Stra8 (Suzuki et al., 2010, 2012). CNOT1
was also reported to interact with IGF2 mRNA-binding protein 1
(IGF2BP1, also known as IMP1; Hämmerle et al., 2013). In human
liver cancer cells, CCR4–NOT takes part in the posttranscriptional
repression of the long noncoding RNA highly up-regulated in liver
cancer (HULC), to which IGF2BPs speciﬁcally bind (Hämmerle
et al., 2013).
CNOT1 is a key player in linking the CCR4–NOT complex
to miRNA-mediated repression (Figure 1B). Human GW182
proteins (also known as TNRC6A, TNRC6B, and TNRC6C), Arg-
onaute (AGO)-binding partners and crucial effectors of miRISCs
(Fabian and Sonenberg, 2012), were shown to directly interact
with CNOT1 as well as PAN3 (Braun et al., 2011; Chekulaeva et al.,
2011; Fabian et al., 2011). The GW182 proteins provide a plat-
form for CCR4–NOT and PAN2–PAN3 to cause deadenylation
of miRNA–target mRNAs (Braun et al., 2011; Chekulaeva et al.,
2011; Fabian et al., 2011). In addition, CCR4–NOT is also required
for silencing unadenylated RNA (Braun et al., 2011; Chekulaeva
et al., 2011). Recent studies showed that the RNA helicase DDX6,
a translational repressor and decapping activator, also interacts
with CNOT1 through the MIF4G domain and this interaction
is important for miRNA repression (Chen et al., 2014; Mathys
et al., 2014). These ﬁndings propose that CCR4–NOT also plays
an important role in miRNA-mediated translational suppression
via recruitment of DDX6.
CNOT1 is commonly involved in mRNA decay in eukaryotes,
including Drosophila melanogaster (Eulalio et al., 2007; Temme
et al., 2010) and Schmidtea mediterranea (freshwater planarian)
stem cells (Solana et al., 2013). Knockdown of planarian NOT1
increases stem cell speciﬁc-mRNAs with elongated poly(A) tails
and leads to failure of cell differentiation (Solana et al., 2013).
Remarkably, a single deletion of only the NOT1 gene among the
CCR4–NOT components causes lethality in Saccharomyces cere-
visiae, while double deletion of the CCR4 and CAF1 genes does
not cause lethality (Maillet et al., 2000), which also suggests that
CNOT1 provides not only a scaffold function for the CCR4–NOT
deadenylase complex but also multiple other functions that are
important for cellular homeostasis.
Transcriptional regulation is considered one of the most
important functions of CNOT1, as Not1p is known to regulate
transcription by RNA polymerase II in yeast (Lee et al., 1998).
In MCF-7 human breast cancer cells that are positive for estro-
gen receptor α (ERα), CNOT1 interacts with ERα through the
LXXLL motif and represses the ligand-dependent transcriptional
activation of ERα (Winkler et al., 2006). CNOT1 can also inter-
act with another member of the nuclear receptor superfamily,
retinoid X receptor α (RXRα), and suppress RXR-mediated tran-
scription in a ligand-dependent fashion (Winkler et al., 2006).
In addition, CNOT1 as well as CNOT2 and CNOT3 sup-
presses the expression of trophectoderm transcription factors
and plays a critical role in maintaining the state of human
and mouse embryonic stem cells (ESCs), contrary to what
occurs in planarian stem cells (Zheng et al., 2012; See details in
Section “CNOT2 and CNOT3”). A genome-wide RNAi screen
identiﬁed CNOT1 and CNOT2 as transcriptional and/or higher-
order regulators of major histocompatibility complex class II
molecules (MHC-II) in human melanoma MelJuSo cells (Paul
et al., 2011).
Some clinical studies indicate that CNOT1 single nucleotide
polymorphisms (SNPs) are relevant to physiological function,
carcinogenesis, and the clinical outcome of disease. A locus in
chromosome 16q21, which includes an intronic SNP within the
CNOT1 gene, was newly identiﬁed as a modulator of the QT inter-
val duration of the electrocardiogram in two independent studies
(Newton-Cheh et al., 2009; Pfeufer et al., 2009). NOT1 was also
identiﬁed as a key factor that was essential for heart functions
using a genome-wide in vivo RNAi screen in Drosophila (Neely
et al., 2010). In addition, SNPs within the CNOT1 and CNOT6
genes are associated with susceptibility to B-cell pediatric acute
lymphoblastic leukemia (ALL;Gutierrez-Camino et al., 2014). The
CNOT1 SNP in dendritic cells (DCs) of 18 HIV patients was also
associated with the response to DC-based immune therapy, as
determined based on the plasma viral load (Moura et al., 2014).
These ﬁndings suggest that CNOT1 is deeply involved in the func-
tions of the cardiovascular, hematopoietic, and immune systems
in humans.
Finally, Cnot1 knockout (KO) mice died during embryonic
development (unpublished). Analyses of Cnot1KO mice and heart
or immunocyte-speciﬁc Cnot1 conditional KO (cKO) mice would
be an attractive strategy to clarify the molecular mechanism by
which CNOT1 contributes to the maintenance of proper physio-
logical functions in mammals. Findings from further studies are
awaited.
CNOT2 AND CNOT3
CNOT2 and CNOT3 are structurally similar, having a unique
conserved domain, i.e., the NOT-box, which is localized at the
C-termini of CNOT2 and CNOT3 (Zwartjes et al., 2004). The
NOT-box of CNOT2 is involved in transcriptional regulation
through an interaction with histone deacetylase 3 (HDAC3),
which is associated with the retinoic acid (RA) receptor, thyroid-
hormone receptor (SMRT), or nuclear hormone receptor co-
repressor (NCoR; Zwartjes et al., 2004; Jayne et al., 2006). The
CNOT2 and CNOT3 proteins directly interact with each other
in various eukaryotes (Ito et al., 2011b; Bawankar et al., 2013;
Boland et al., 2013), and this interaction is achieved through their
C-terminal regions comprising the NOT-boxes (Bawankar et al.,
2013; Boland et al., 2013). In addition, CNOT2 mediates the inter-
action between CNOT3 and CNOT1 (Lau et al., 2009; Ito et al.,
2011b; Boland et al., 2013). Consistently, depletion of CNOT2
in HeLa cells affects the integrity of the CCR4–NOT complex. Its
depletion extensively decreases the expression level of CNOT3 and
modestly decreases the expression of other CNOTs by destabilizing
them (Ito et al., 2011b).
CNOT2 and CNOT3 do not possess catalytic domains, and
there has been no report about their direct enzymatic activities.
However, increasing evidence indicates that CNOT2 and CNOT3
function as positive modulators of the catalytic activities of the
CCR4–NOT deadenylase and promote the degradation of target
mRNAs. For instance, depletion of Not2p, Not3p, or Not5p sup-
presses cellular deadenylase activity, albeit slightly, and results in
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the stabilization of mRNAs in yeast (Tucker et al., 2002). It is note-
worthy that this function of CNOT2 and CNOT3 is pertinent to
various biological phenomena. A NOT2 or NOT5 mutation is syn-
thetically lethal with a CAF1 orCCR4 deletion (Bai et al., 1999). By
contrast, a NOT3 mutation with either a CAF1 or CCR4 deletion
does not result in synthetic lethality (Bai et al., 1999), suggesting
that Not5p is more essential than Not3p for the function of the
CCR4–NOT complex in yeast.
Also, in higher eukaryotes, CNOT2 and CNOT3 regulate
mRNA decay in various physiological processes. In Drosophila
S2 cells, depletion of NOT2 affects the length of mRNA poly(A)
tails (Temme et al., 2004). In addition, NOT3 directly interacts
with the RNA-binding protein Bic-C, which is required for mater-
nal patterning in the Drosophila embryo, and thus contributes
to recruitment of the catalytic subunit of the deadenylase to its
target mRNAs (Chicoine et al., 2007). In mammals, CNOT3 is
essential for embryonic viability because deﬁciency in CNOT3
results in lethality of mice at early embryonic stages (Neely et al.,
2010; Morita et al., 2011). Moreover, Cnot3+/− mice are lean
and display resistance to high-fat-diet (HFD)-induced obesity
compared to control mice due to enhanced metabolic rates and
glucose tolerance (Morita et al., 2011). We clariﬁed that a reduc-
tion in CNOT3 expression affects the stability of speciﬁc mRNAs
encoding proteins mainly involved in energy metabolism, such as
pyruvate dehydrogenase kinase, isozyme 4 (PDK4), and IGF bind-
ing protein 1 (IGFBP1), in the livers of Cnot3+/− mice (Morita
et al., 2011). Cnot3+/− mice also show osteopenia and exacer-
bated aging-induced osteoporosis with enhanced bone resorption
(Watanabe et al., 2014). It was also found that the mRNA expres-
sion of receptor activator of nuclear factor-κB (RANK), but
not RANK ligand (RANKL), is up-regulated in Cnot3+/− mice
and its mRNA stability is enhanced by Cnot3-deﬁciency in bone
marrow-derived macrophages (Watanabe et al., 2014). These ﬁnd-
ings suggest that CNOT3-mediated regulation of the CCR4–NOT
deadenylase is essential for a wide-range of physiological processes
in mice.
In cultured mammalian cells, CNOT2 and CNOT3 report-
edly affect cell cycle progression through the regulation of mRNA
turnover. Knockdown of CNOT2 in HeLa cells impairs the dead-
enylase activity of the CCR4–NOT complex and decreases the
number of P-bodies, as is the case for CNOT1 (Ito et al., 2011a,b).
The cells, in turn, undergo caspase-dependent apoptosis, most
likely due to the ER-stress induced by overproduction of the pro-
teins that results from elevated levels of the stabilized mRNAs (Ito
et al., 2011a,b). By contrast, knockdown of CNOT3 speciﬁcally
increases the expression of MAD1 by stabilizing its mRNA and
induces mitotic arrest of HeLa cells (Takahashi et al., 2012).
Transcriptional regulation is another important function of
CNOT2 andCNOT3. Recently, a CNOT2-centered transcriptional
network module was reported to be relevant for the susceptibility
of breast cancer to metastasis (Faraji et al., 2014). CNOT2 also reg-
ulates the metastasis of murine breast cancer in a mouse xenograft
model (Faraji et al., 2014). Regarding CNOT3, a genome-wide
RNAi screen identiﬁed CNOT3 as one of the molecules that form
a unique module in the transcriptional network and are essen-
tial for mouse ES cell self-renewal (Hu et al., 2009). CNOT2 and
CNOT3 aswell as CNOT1 contribute to themaintenance of mouse
and human ESC identity, namely self-renewal and pluripotency,
possibly through suppressing the expression of trophectoderm
transcription factors (Zheng et al., 2012). Consistent with this,
the expression of CNOT1, CNOT2, and CNOT3 closely correlates
with the state of pluripotency (Zheng et al., 2012). It is notewor-
thy that single or even combined silencing of the deadenylase
subunits does not affect the differentiation of ESCs, suggest-
ing that transcriptional repression by CNOT1/CNOT2/CNOT3
is a key function in this phenomenon (Zheng et al., 2012). A
global in vivo Drosophila RNAi screen identiﬁed NOT3 in addi-
tion to NOT1 as a critical regulator of heart function (Neely et al.,
2010). In fact, Cnot3+/− mice exhibit spontaneous impairment
of cardiac contractility and develop severe cardiomyopathy in
response to artiﬁcial cardiac stress by transverse aortic constric-
tion (TAC) surgery (Neely et al., 2010). These phenomena aremost
likely due to decreased CNOT3 expression, resulting in the dys-
function of chromatin modiﬁcation at the promoter regions of
genes relevant to heart functions (Neely et al., 2010). However,
in this case, it remains to be investigated whether CNOT3 also
affects the stability of speciﬁc mRNAs in the heart (Neely et al.,
2010).
Finally, several reports suggest that dysregulation of CNOT3
expression is relevant to a wide-range of human diseases.
SNP analysis revealed that there is a signiﬁcant association
between CNOT3 polymorphism and cardiac repolarization dura-
tion (Neely et al., 2010) or susceptibility to ankylosing spondylitis
(Díaz-Peña et al., 2012). In addition, CNOT3 was identiﬁed
as a modiﬁer of mutations in the causative gene of retini-
tis pigmentosa, PRPF31, which prevents the manifestation of
this disease (Venturini et al., 2012). Importantly, CNOT3 was
also identiﬁed as a tumor suppressor that is mutated in adult
T-cell ALL, and its knockdown indeed caused tumors in a sen-
sitized D. melanogaster model (De Keersmaecker et al., 2013). The
mechanisms by which CNOT3 contributes to the prevention of
carcinogenesis are unknown. As such, further studies are neces-
sary to clarify the molecular functions of CNOT3, especially by
addressing which of the two major mechanisms, mRNA decay
or transcriptional regulation, mainly contributes to individual
biological phenomena.
CNOT6 AND CNOT6L
The evolutionarily conserved proteinCCR4 is one of the two dead-
enylase subunits of the yeast CCR4–NOT complex and belongs
to the EEP superfamily (Collart and Panasenko, 2012; Winkler
and Balacco, 2013). Yeast CCR4 (Ccr4p) was originally identi-
ﬁed as a regulator of ADH2 in the yeast Saccharomyces cerevisiae
(Denis, 1984). In a series of genetic studies, Ccr4p was shown to be
involved in biological functions such as the DNA damage response
(Collart and Panasenko, 2012).
CCR4 is characterized by the presence of two highly conserved
domains: a C-terminal deadenylase domain and an amino-
terminal leucine-rich repeat (LRR) domain. The LRR domain is
essential for binding to CAF1 and incorporation into the CCR4–
NOT complex (Winkler and Balacco, 2013). However, there are
somedifferences in the structure and composition of CCR4 among
species. First, the activation domain located in the N-terminal-
most region of Saccharomyces cerevisiae Ccr4p is not present in
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its orthologs in other species of eukaryotes, including mammals
(Morita et al., 2007). Second, there is only a single CCR4 in yeasts
as well as in the metazoans D. melanogaster and Caenorhabditis
elegans, while two orthologs, CNOT6 (also known as CCR4a) and
CNOT6L (also known as CCR4b), exist in vertebrates, includ-
ing Xenopus laevis, Danio rerio, Mus musculus, and Homo sapiens
(Dupressoir et al., 2001; Morita et al., 2007; Cooke et al., 2010;
Winkler and Balacco, 2013).
CCR4 has been implicated in a variety of biological functions,
as inferred from genetic and RNA interference experiments in
many biological species (Goldstrohm and Wickens, 2008). It is
worth noting that CCR4 family proteins are not essential for
the viability of the organisms studied to date (Goldstrohm and
Wickens, 2008). Among the various physiological roles of CCR4
over multiple species, the role of CCR4 during the early devel-
opment of various organisms has been well characterized. For
instance, mutations in the Drosophila gene twin, which encodes
CCR4, affect female reproductive capacity and display defects in
the self-renewal of germline stem cells (Temme et al., 2004; Morris
et al., 2005; Zaessinger et al., 2006; Joly et al., 2013). In particu-
lar, the expression of the mei-P26 mRNA is speciﬁcally regulated
by CCR4 through the RNA-binding proteins Nanos and Pumilio
during germline stem cell self-renewal in Drosophila (Joly et al.,
2013). By contrast, the poly(A) tail length of mRNAs was globally
increased by depletion of CCR4 in C. elegans germ cells, suggest-
ing the CCR4–NOT complex plays a key role in general mRNA
metabolism during early development in C. elegans (Nousch et al.,
2013).
The mammalian CCR4 orthologs CNOT6 and CNOT6L have
also been recently studied. The crystal structural analysis of human
CNOT6L revealed that its deadenylase domain is remarkably sim-
ilar to that of other EEP proteins and selectively interacts with
poly(A) residues (Wang et al., 2010). In addition, in vitro dead-
enylation assays revealed that CNOT6L prefers poly(A) RNA to
poly(A) DNA, indicating that CNOT6L preferentially functions as
deadenylase of mRNAs (Wang et al., 2010).
CNOT6 and CNOT6L were reported to be mutually exclusive
in the human CCR4–NOT complex in HeLa S3 cells, implying that
the two paralogs have compensatory roles inmRNAdeadenylation
(Lau et al., 2009). Indeed, both CNOT6 and CNOT6L contribute
to efﬁcient cell growthof MCF-7 cells (Mittal et al., 2011). It should
be noted that microarray analysis demonstrated that depletion of
CNOT6 has little effect on mRNA levels compared to depletion
of CNOT6L (Mittal et al., 2011). In addition, the tissue distribu-
tion of CNOT6 and CNOT6L in mice is distinctive. CNOT6L is
ubiquitously expressed in various tissues, while CNOT6 is highly
expressed in testis, ovary, thymus, and spleen (Chen et al., 2011).
Moreover, CNOT6L, but not CNOT6, inﬂuences cell proliferation
of murine ﬁbroblasts (NIH3T3 cells) through regulation of the
Cdkn1b mRNA (Morita et al., 2007). These ﬁndings indicate that
CNOT6 and CNOT6L have discrete roles in addition to a mutually
overlapping role in cells. Both Cnot6 KO and Cnot6l KO mice are
viable and fertile (unpublished). Further studies with these KO
mice would unravel the physiological differences between CNOT6
and CNOT6L.
Recent study demonstrated that signiﬁcant copy number loss
of CNOT6L was present in human colon adenocarcinoma samples
(Tay et al., 2011). The expression of CNOT6L and CNOT7 was
reportedly down-regulated in samples of leukemia cells taken from
ALL and AML (acute myeloid leukemia) patients compared to
normal blood cells, while the expression of CNOT6 was slightly
up-regulated (Maragozidis et al., 2012). In addition, SNPs in the
CNOT1 andCNOT6 geneswere signiﬁcantly associatedwithB-cell
ALL susceptibility (Gutierrez-Camino et al., 2014). However, the
involvement of CNOT6 andCNOT6L in the onset and progression
of cancer is still not clariﬁed. Apparently, further studies investi-
gating the function of CNOT6 and CNOT6L in various diseases
are required.
Finally, there are additional members of the mammalian
CCR4 family: Nocturnin (CCR4c), Angel1 (CCR4d), Angel2
(CCR4e), and 2′phosphodiesterase (2′PDE; Goldstrohm and
Wickens, 2008). These proteins lack a LRR domain, which indi-
cates that they are not always components of the CCR4–NOT
complex (Godwin et al., 2013). Their physiological functions are
still largely unknown, and we would like to omit these details in
this review (see Poulsen et al., 2011; Godwin et al., 2013).
CNOT7 AND CNOT8
Caf1, which possesses a ribonuclease (RNase) D domain from the
DEDD superfamily, is the other core deadenylase subunit of the
CCR4–NOT complex (Collart and Panasenko, 2012; Winkler and
Balacco, 2013). Initially, yeast Caf1 (Caf1p) was identiﬁed as a pos-
sible transcriptional regulator required for glucose-derepression in
Saccharomyces cerevisiae (Sakai et al., 1992). Subsequently, Tucker
et al. found that Caf1p together with Ccr4p is a major cytoplasmic
mRNAdeadenylase (Tucker et al., 2001). Since then, deadenylation
by Caf1 has been intensively studied.
The amino acid sequences of CAF1 orthologs are highly con-
served across species (Winkler andBalacco,2013). InTrypanosoma
brucei, no ortholog for CCR4 was found, and CAF1 is the only
deadenylase unit of the trypanosomeCCR4–NOT complex, which
is crucial for the deadenylation and subsequent degradation of
many mRNAs (Schwede et al., 2008). In Drosophila, although both
CCR4 and CAF1 are involved in the regulation of bulk mRNA
poly(A) deadenylation, the catalytic activity of Caf1 is considered
more potent than that of CCR4 (Temme et al., 2004, 2010). By
contrast, Ccr4p is the dominant deadenylase, and Caf1p is dis-
pensable in the presence of the catalytic activity of Ccr4p in yeast
(Tucker et al., 2002). However, there remains a possibility that
Caf1p is responsible for the regulation of deadenylation of speciﬁc
mRNAs in yeast (Tucker et al., 2002; Wiederhold and Passmore,
2010). Thus, the biological signiﬁcance of CAF1 differs among
eukaryotes, even though the molecular structures of its orthologs
are well conserved.
In mammals including humans, there are two orthologs of
CAF1: CNOT7 (hCAF1a) and CNOT8 (hCAF1b). Amino acid
sequence analysis of human CNOT7 and CNOT8 demonstrated
that there is a high degree of homology between them (Bianchin
et al., 2005; Winkler and Balacco, 2013). Human CNOT7 and
CNOT8 bind the middle region of CNOT1 through its MIF4G
domain, which is composed of antiparallel pairs of α-helices
(Basquin et al., 2012; Petit et al., 2012; Bawankar et al., 2013). In
addition, yeast two-hybrid analysis revealed that CNOT6 directly
binds CNOT7 and CNOT8, but not CNOT1 (Lau et al., 2009).
www.frontiersin.org August 2014 | Volume 5 | Article 286 | 5
Shirai et al. Physiological roles of CCR4–NOT complex
These ﬁndings suggest that the interaction of CNOT7 and CNOT8
with CNOT1 is essential for CNOT6 and CNOT6L to be inte-
grated into theCCR4–NOTcomplex and exert their deadenylation
functions.
Both CNOT7 and CNOT8 are ubiquitously expressed in adult
mouse tissues (Chen et al., 2011). It is worth mentioning that
high expression levels of both CNOT7 and CNOT8 proteins were
detected, especially in thymus, spleen, ovary, and testis, and their
expression patterns were similar (Chen et al., 2011). The com-
bined depletion of CNOT7 and CNOT8 as well as CNOT6 and
CNOT6L resulted in the strong inhibition of ARE-containing
β-globin mRNA decay in human HTGM5 cells (Schwede et al.,
2008). In addition,CNOT7andCNOT8were reported tobemutu-
ally exclusive in the CCR4–NOT complex in HeLa S3 cells, as is the
case for CNOT6 and CNOT6L (Lau et al., 2009). These ﬁndings
suggest that the Caf1 paralogs are important for mRNA deadeny-
lation in mammals, and each has overlapping functions. Indeed,
CNOT7 and CNOT8 are required for the proliferation of MCF7
human breast cancer cells and redundantly repress the antiprolif-
erative gene PMP22 through their deadenylase activities (Aslam
et al., 2009).
It is noteworthy that CNOT7 and CNOT8 are capable of
binding BTG/Tob proteins (BTG1, BTG2/PC3/Tis21, BTG3/ANA,
BTG4/PC3B,Tob1, andTob2),which are characterized by the pres-
ence of a conserved BTG domain and regulate cell cycle progres-
sion (Winkler, 2010; Winkler and Balacco, 2013). The interaction
with CNOT7/CNOT8 is required for the anti-proliferative activi-
ties of Tob proteins in various types of mammalian cells (Horiuchi
et al., 2009; Doidge et al., 2012b; Ezzeddine et al., 2012). Impor-
tantly, Tob functions as a guide molecule for the CCR4–NOT
complex to target mRNAs through an interaction with CNOT7
(Doidge et al., 2012a). Tob is capable of associating with the
general RNA-binding protein, poly(A)-binding protein (PABP),
and recruits the CCR4–NOT complex to initiate mRNA decay
(Funakoshi et al., 2007). Moreover, Tob also mediates the recruit-
ment of the CCR4–NOT deadenylase to speciﬁc mRNAs, such
as MYC, to which CPEB proteins bind (Hosoda et al., 2011;
Ogami et al., 2014). There are some reports that Tob proteins
and BTG2 activate the deadenylation of mRNAs in cultured cells
(Ezzeddine et al., 2007, 2012; Mauxion et al., 2008). However,
there is an opposing report that BTG2 inhibits deadenylation
by CNOT7/CNOT8 in vitro (Yang et al., 2008). As such, regula-
tion of the deadenylation activity of CNOT7/CNOT8 by BTG/Tob
proteins might be dependent on extracellular and intracellular
circumstances. Further studies should clarify this complicated
molecular network.
CNOT7 is known to be deeply involved in cellular signaling
pathways through interacting with various types of proteins in
addition to BTG/Tob proteins. CNOT7 regulates class I and II
interferon (IFN) pathways by controlling signal transducer and
activator of transcription 1 (STAT1) trafﬁcking through an inter-
actionwith its latent formanddegrading STAT1-regulatedmRNAs
through its deadenylase activity (Chapat et al., 2013). Remark-
ably, Cnot7-deﬁciency results in physiological anomalies in mice.
Cnot7 KO male mice exhibit severe infertility associated with
oligo-astheno-teratozoospermia (Berthet et al., 2004; Nakamura
et al., 2004). CNOT7 physically interacts with RXR beta (Rxrb)
and is involved in spermatogenesis by functioning as a coregulator
of Rxrb in testicular somatic cells (Nakamura et al., 2004). More-
over, Cnot7 KO mice show increased bone mass, and CNOT7 was
found to function as a suppressor of bone morphogenetic pro-
tein (BMP) signaling (Washio-Oikawa et al., 2007). These ﬁndings
suggest that CNOT7 regulates the balance in various biological
processes in mammals. Both Cnot7 and Cnot8 KO mice would be
useful tools to clarify the functional difference between CNOT7
and CNOT8.
There are some reports that CNOT7 and CNOT8 are relevant
to the development and progression of cancer. The expres-
sion of CNOT7 was down-regulated in ALL and AML patients
(Maragozidis et al., 2012), and the expression of CNOT8 was
elevated in primary colorectal carcinoma and metastatic legions
compared to the normal mucosa (Seiden-Long et al., 2006). It
remains to be investigated how CNOT7 and CNOT8 contribute to
the development and progression of cancer.
CNOT9
Rcd1 (required for cell differentiation 1) was originally identiﬁed
as a factor essential for nitrogen starvation-induced sexual differ-
entiation in the ﬁssion yeast Schizosaccharomyces pombe (Okazaki
et al., 1998). Shortly after this discovery, its Schizosaccharomyces
cerevisiae homolog, Caf40, was identiﬁed by mass spectrometry
analysis as a component of the CCR4–NOT complex (Chen et al.,
2001). The amino acid sequences of Rcd1/Caf40 orthologs are
highly conserved among eukaryotes (Okazaki et al., 1998; Garces
et al., 2007).
CNOT9, the mammalian ortholog of Rcd1 and Caf40
(Collart and Timmers, 2004), acts as a transcriptional cofactor
that plays a critical role inRA-induced differentiation of F9 embry-
onic teratocarcinoma cells and in lung development, through an
association with a transcription complex containing activation
transcription factor-2 (ATF-2) and RA receptors (RARs) in an
RA-dependent fashion (Hiroi et al., 2002). CNOT9 interacts with
nuclear hormone receptor transcriptional coactivator (NRC)-
interacting factor 1 (NIF-1; Garapaty et al., 2008). NIF-1 interacts
with NRC, which is a coactivator of nuclear hormone receptors,
and regulates its activities (Mahajan et al., 2002). CNOT9 also
interactswith c-Myb,which is a proto-oncogene product and tran-
scription factor involved inmyeloid cell differentiation (Haas et al.,
2004). In addition, CNOT9 was isolated as an erythropoietin-
responsive gene that is potentially important for hematopoietic
cell development (Gregory et al., 2000). Thus, the involvement
of CNOT9 in the control of growth and differentiation of mam-
malian tissues, especially of the hematopoietic system, may be
highlighted.
Although CNOT9 has not been shown to carry deadenylase
activity, its involvement in deadenylation and/or mRNA decay
was recently implicated by structural analysis (Chen et al., 2014;
Mathys et al., 2014). CNOT9 comprises six armadillo repeats
(ARM repeat domain) and forms a homodimer or alternatively
interacts with CNOT1 (Garces et al., 2007; Chen et al., 2014;
Mathys et al., 2014). The interaction takes place between the
ARM repeat domain of CNOT9 and the DUF3819 domain of
CNOT1, and the consequent binary complex provides binding
sites for GW182 (Chen et al., 2014; Mathys et al., 2014). The ARM
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repeat domain is known to be involved in protein–protein inter-
actions, as described above. Interestingly, a recent study revealed
that the ARM repeat domain of β-catenin is associated with RNA
binding and forming RNA–protein complexes (Kim et al., 2012),
which suggests that CNOT9 is also capable of interacting with
RNA through the ARM repeat domain. Consistently, a previous in
vitro binding assay demonstrated the interaction between CNOT9
and single-stranded DNA polymers, i.e., poly(dC), poly(dG), and
poly(dT), but not poly(dA) (Garces et al., 2007).
Acting as a transcriptional regulator and/or an mRNA silenc-
ing protein, CNOT9 is expected to play important roles in various
biological events in mammals. Increasing data indicate that the
aberrant expression of CNOT9 is relevant to disease, as described
below. First, some evidence suggests that CNOT9 is involved in
mammary carcinogenesis. CNOT9 is frequently up-regulated in
human breast cancer specimens and cell lines (Ajiro et al., 2009),
and its expression is extremely low in normal human tissues,
except testis, which suggests that CNOT9 is a cancer antigen
(Ajiro et al., 2009). It should be noted, however, that the expres-
sion of CNOT9 is readily detectable in various murine adult
tissues, including testis, ovary, thymus, brain, and lung (Chen
et al., 2011). Short hairpin RNA (shRNA)-mediated suppression
of CNOT9 drastically suppresses the proliferation of breast cancer
cells (Ajiro et al., 2009). In addition, CNOT9 forms a large com-
plex consisting of Grb10, Grb10-interacting protein 1 (GIGYF1),
GIGYF2, and Akt, all of which are components of epidermal
growth factor receptor (EGFR) downstream signaling (Ajiro et al.,
2010). The Akt phosphorylation that is induced by EGFR signal-
ing is attenuated in the absence of CNOT9 (Ajiro et al., 2010),
which suggests that CNOT9 enhances EGFR signaling and con-
tributes to carcinogenesis and progression of cancer, particularly
in mammary glands. Second, Cnot9-deﬁcient mice are embry-
onic lethal (unpublished). Further analyses of Cnot9 null and
cKO mice would provide insights into how CNOT9 regulates
physiological processes through interactions with various types
of molecules.
CNOT10 AND CNOT11
CNOT10 is a unique component of the CCR4–NOT com-
plex in that its orthologs exist in eukaryotes, except in fungi
(Bartlam and Yamamoto, 2010; Panepinto et al., 2013). Recent
proteomic analysis uncovered that C2orf29 stably associates with
the human CCR4–NOT complex (Lau et al., 2009). Ortholog of
C2orf29 is also found in all eukaryotes examined except in yeast
(Mauxion et al., 2013). In the vertebrate CCR4–NOT complex,
C2orf29 together with CNOT10 form a module that interacts
with CNOT1. This interaction takes place through direct bind-
ing of C2orf29 with the N-terminus of CNOT1 in D. melanogaster
and human cells (Bawankar et al., 2013; Mauxion et al., 2013). In
addition, expression of CNOT10 and C2orf29 reciprocally stabi-
lizes each other. C2orf29 was proposed to be renamed CNOT11
and is now recognized as a bona ﬁde subunit of the CCR4–NOT
complex.
Regarding the function of CNOT10/CNOT11, its ability to pro-
mote deadenylation of bound mRNAs was shown in tethering
assays to be most likely due to recruitment of the catalytic mod-
ule (Bawankar et al., 2013). However, depletion of CNOT11 did
not affect the deadenylation rate of a β-globin mRNA reporter in
human cells (Mauxion et al., 2013), suggesting that CNOT11 itself
is not directly involved in deadenylation. In contrast, depletion
of CNOT10 impaired the deadenylation of various mRNAs and
inhibited the proliferation of trypanosomes (Färber et al., 2013).
This discrepancy in the role of CNOT10/CNOT11 might result
from constitutional and structural differences between the human
and trypanosome CCR4–NOT complexes. Indeed, depletion of
CNOT10 decreased the level of CNOT1 in trypanosomes, while
this phenomenon was not observed in human cells (Färber et al.,
2013). This ﬁnding suggests that the role of theCNOT10/CNOT11
module could differ among species, even though the module is
conserved. Finally, Cnot10-deﬁciency in mice causes embryonic
lethality (unpublished). The generation and analyses of Cnot11
KO mice would be necessary in future studies.
CONCLUDING REMARKS AND PERSPECTIVES
The core members of the CCR4–NOT complex were originally
identiﬁed and characterized in yeast (Collart, 2003). Recent stud-
ies, including structural and biochemical analyses, have unveiled
that the mammalian CCR4–NOT complex harbors both con-
served and mammalian-speciﬁc functions. In addition, each
subunit has distinct multifunctional roles through interactions
with a wide-range of molecules. By contrast, the deadenylase
units, namely CNOT6/CNOT6L and CNOT7/CNOT8, have over-
lapping functions. The biological signiﬁcance of the versatile
and yet conserved roles, to a certain extent, has not been well
appreciated, although this complexity makes research on the
CCR4–NOT complex intriguing. Many questions remain to be
addressed. For instance, what are the roles of CNOT10 and
CNOT11 in the murine and human CCR4–NOT complexes?
Table 1 | Phenotypes of KO mice of the CCR4–NOT complex subunits.
Gene Genotype Dysregulation in the molecular functions Biological anomaly Reference
Cnot3 −/− Unknown Embryonic lethality (E6.5) Neely et al. (2010), Morita et al. (2011)
+/− Up-regulation of Pdk4 and Igfbp1 mRNA Leanness Morita et al. (2011)
Up-regulation of Rank mRNA Osteopenia Watanabe et al. (2014)
Transcriptionally inactive chromatin Cardiac dysfunction Neely et al. (2010)
Cnot7 −/− Impaired Rxrb signaling Male sterility Berthet et al. (2004), Nakamura et al. (2004)
Enhanced BMP signaling Increased bone mass Washio-Oikawa et al. (2007)
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Strikingly, deﬁciency in each component of the CCR4–NOT com-
plex, including CNOT1, CNOT3, CNOT9, and CNOT10, but not
the deadenylase subunits CNOT6, CNOT6L, and CNOT7, in mice
leads to embryonic lethality, suggesting that the CCR4–NOT com-
plex is indispensable for embryonic development (unpublished).
We are currently investigating whether Cnot2 KO and Cnot8
KO mice also exhibit developmental anomalies. Furthermore,
the organ-speciﬁc functions of each CCR4–NOT component in
mammals remain to be elucidated and could be addressed by
generating cKO mice of each subunit in various organs. All the
phenotypes of KO mice of each CCR4–NOT subunit reported are
summarized in Table 1. Further analyses of null and cKO mice
will help to clarify the inscrutable functions of the CCR4–NOT
complex.
In summary, the CCR4–NOT complex globally regulates
mRNA metabolism from transcriptional initiation to mRNA
degradation. Thus, the CCR4–NOT complex has great inﬂu-
ence on biological events via the regulation of consequent protein
expression. It is becoming clear that there is a relationship between
the CCR4–NOT complex and various diseases. Dissection of the
physiological processes that are regulated byCCR4–NOT, amRNA
metabolism-controlling machinery, would be a novel and intrigu-
ing approach to elucidate the cause of disease, both at onset and
upon progression. Further progress in the research on mRNA
metabolism regulated by CCR4–NOT is anticipated.
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